Understanding Practice: Factors influencing management of cognitive and behavioural changes in MND. A qualitative study using the Theoretical Domains Framework.
Friday, June 13, 2025 |
12:10 PM - 12:20 PM |
Overview
Details
⏲️ 12.10pm - 12.30pm
⌛ 20-minutes
📚 Assumed knowledge of attendees: Intermediate (Some previous learning/working knowledge of topic e.g. treated a few cases)
Presenter
Understanding Practice: Factors influencing management of cognitive and behavioural changes in MND. A qualitative study using the Theoretical Domains Framework.
12:10 PM - 12:30 PMPresentation summary
Refrences
Francis, R., Attrill, S., Radakovic, R., & Doeltgen, S. (2023). Exploring clinical management of cognitive and behavioural deficits in MND. A scoping review. Patient Education and Counseling, 116, 107942. https://doi.org/https://doi.org/10.1016/j.pec.2023.107942
Gray, D., & Abrahams, S. (2022). International evaluation of current practices in cognitive assessment for motor neurone disease. British Journal of Neuroscience Nursing, 18(1), 38-44. https://doi.org/10.12968/bjnn.2022.18.1.38
Leigh, P. N., Abrahams, S., Al-Chalabi, A., Ampong, M. A., Goldstein, L. H., Johnson, J., Lyall, R., Moxham, J., Mustfa, N., Rio, A., Shaw, C., & Willey, E. (2003). The management of motor neurone disease [Review]. Neurology in Practice, 74(4), iv32-iv47. https://www.scopus.com/inward/record.uri?eid=2-s2.0-10744223929&partnerID=40&md5=782b2d5ee1f8a6d7a118dc60b594101a
Pinto, C., Geraghty, A. W. A., Yardley, L., & Dennison, L. (2021). Emotional distress and well-being among people with motor neurone disease (MND) and their family caregivers: a qualitative interview study. BMJ Open, 11(8), e044724. https://doi.org/10.1136/bmjopen-2020-044724
Radakovic, R., Radakovic, C., Abrahams, S., Simmons, Z., & Carroll, A. (2024). Quality of life, cognitive and behavioural impairment in people with motor neuron disease: a systematic review. Quality of Life Research, 1-12.
Trucco, A. P., Backhouse, T., & Mioshi, E. (2024). Describing and assessing behavioural symptoms in amyotrophic lateral sclerosis with and without frontotemporal dementia: a scoping review. Curr Opin Neurol, 37(5), 603-610. https://doi.org/10.1097/wco.0000000000001293
**********
The information contained in this program is current at of the time of publishing but is subject to changes made without notice.
Disclaimer: © (2024) The Speech Pathology Association of Australia Limited. All rights reserved.
Important Notice, please read: The views expressed in this presentation and reproduced in these materials are not necessarily the views of, or endorsed by, The Speech Pathology Association of Australia Limited ("the Association"). The Association makes no warranty or representation in relation to the content, currency or accuracy of any of the materials comprised in this presentation. The Association expressly disclaims any and all liability (including liability for negligence) in respect of use of these materials and the information contained within them. The Association recommends you seek independent professional advice prior to making any decision involving matters outlined in this presentation including in any of the materials referred to or otherwise incorporated into this presentation.
.
